BCL9 Antikörper (AA 51-150)
-
- Target Alle BCL9 Antikörper anzeigen
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Bindungsspezifität
- AA 51-150
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human BCL9
- Isotyp
- IgG
- Top Product
- Discover our top product BCL9 Primärantikörper
-
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 231-340) antibody
BCL9 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) antibodyBCL9 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 1036-1135) antibodyBCL9 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2D4 unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 1118-1327) antibodyBCL9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 272-304) antibodyBCL9 Reaktivität: Human, Maus WB, IF Wirt: Kaninchen Polyclonal RB53769 unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 1036-1135) antibodyBCL9 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) antibodyBCL9 Reaktivität: Maus WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) antibodyBCL9 Reaktivität: Human DB Wirt: Maus Monoclonal 2071C3a unconjugated
anti-B-Cell CLL/lymphoma 9 (BCL9) (AA 1119-1328) antibodyBCL9 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
- Andere Bezeichnung
- BCL9 (BCL9 Produkte)
- Synonyme
- lgs antikoerper, xbcl9 antikoerper, legless antikoerper, MGC83888 antikoerper, BCL9 antikoerper, 2610202E01Rik antikoerper, 8030475K17Rik antikoerper, A330041G23Rik antikoerper, Gm130 antikoerper, LGS antikoerper, B-cell CLL/lymphoma 9 L homeolog antikoerper, B-cell CLL/lymphoma 9 antikoerper, B cell CLL/lymphoma 9 antikoerper, bcl9.L antikoerper, BCL9 antikoerper, Bcl9 antikoerper
- Hintergrund
-
Synonyms: B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9, Protein legless homolog, BCL9,
Background: Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity.
- Gen-ID
- 607
- UniProt
- O00512
- Pathways
- Stem Cell Maintenance
-
